Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock

Therapeutic Apheresis and Dialysis

Volumn 12, Issue 5, 2008, Pages 374-380

  Kase, Yoichi ^a   Obata, Toru ^a   Okamoto, Yasuhisa ^a   Iwai, Kenichi ^a   Saito, Keita ^a   Yokoyama, Keitaro ^a   Takinami, Masanori ^a   Tanifuji, Yasumasa ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

2 Arachidonylglycerol; Arachidonyl ethanolamine; Direct hemoperfusion therapy; Endocannabinoid; Polymixin B; Septic shock

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ENDOCANNABINOID; ISOPROSTANE DERIVATIVE; POLYMYXIN B;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEMOPERFUSION; HUMAN; LAPAROTOMY; MALE; MEAN ARTERIAL PRESSURE; OXIDATIVE STRESS; PERITONITIS; PRIORITY JOURNAL; SEPTIC SHOCK; SURGICAL DRAINAGE;

AGED; APACHE; ARACHIDONIC ACIDS; CASE-CONTROL STUDIES; ENDOTOXINS; FEMALE; FOLLOW-UP STUDIES; HEMOPERFUSION; HUMANS; MALE; MIDDLE AGED; POLYMYXIN B; POLYUNSATURATED ALKAMIDES; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 53749090720     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2008.00612.x     Document Type: Article

References (25)

1. Kawamata T, Imaizumi H, Yoshida M, Kaneko M. Polymixin B-immobilized fiber improves hemodynamic state in MRSA septic patients. Intensive Care Med 1997 23 : 130 1.
2. Varga K, Wagner JA, Bridgen DT, Kunos G. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 1998 12 : 1035 44.
3. Devane WA, Hanus L, Breuer A et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992 258 : 1946 9.
4. Mechoulam R, Ben-Shabat S, Hanus L et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995 50 : 83 90.
5. Vollmer RR, Cavero I, Ertel RJ, Solomon TA, Buckley JP. Role of the central autonomic nervous system in the hypotension and bradycardia induced by (-)-delta 9-trans-tetrahydrocannabinol. J Pharm Pharmacol 1974 26 : 186 92.
6. Varga K, Lake K, Martin BR, Kunos G. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol 1995 278 : 279 83.
7. Wang Y, Liu Y, Sarker KP et al. Polymyxin-B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett 2000 470 : 151 5.
8. Obata T, Sakurai Y, Kase Y, Tanifuji Y, Horiguchi T. Simultaneous determination of endocannabinoids (arachidonylethanolamide and 2-arachidonylglycerol) and F2-isoprostane (8-epiprostaglandin F2α) by gas chromatography-mass spectrometry-selected ion monitoring for medical samples. J Chromatogr B Anal Technol Biomed Life Sci 2003 792 : 131 40.
9. Obata T. Strategy and principles of the simultaneous analysis of prostanoids by gas chromatography/mass spectrometry/selected-ion monitoring. Anal Chimica Acta 2002 465 : 379 93.
10. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985 13 : 818 29.
11. Vincent JL, Moreno R, Takala J et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996 22 : 707 10.
12. Goris RJ, te Boekhorst TP, Nuytinck JK, Gimbrère JS. Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg 1985 120 : 1109 15.
13. Sugiura T, Kondo S, Sukagawa A et al. 2-Arachidonylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995 215 : 89 97.
14. Kohro S, Imaizumi H, Yamakage M et al. Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis. J Anesth 2006 20 : 11 16.
15. Jarai Z, Wagner JA, Goparaju SK et al. Cardiovascular effects of 2-arachidonyl glycerol in anesthetized mice. Hypertension 2000 35 : 679 84.
16. Sugiura T, Kodaka T, Nakane S et al. Evidence that the cannabinoid CB1 receptor is a 2-arachidonylglycerol receptor. Structure-activity relationship of 2-arachidonylglycerol, ether-linked analogues, and related compounds. J Biol Chem 1999 274 : 2794 801.
17. Dellinger RP, Carlet JM, Masur H et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004 30 : 536 5.
18. Vincent JL, Laterre PF, Cohen J et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005 23 : 400 5.
19. Damas P, Ledoux D, Nys M et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992 215 : 356 62.
20. Naka T, Shinozaki M, Akizawa T, Shima Y, Takaesu H, Nasu H. The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock. Ther Apher Dial 2006 10 : 7 11.
21. Tsushima K, Kubo K, Yoshikawa S et al. Effects of PMX-DHP Treatment for patients with directly induced acute respiratory distress syndrome. Ther Apher Dial 2007 11 : 138 45.
22. Kozak KR, Rowlinson SW, Marnett LJ. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J Biol Chem 2000 27 : 33744 9.
23. Nirodi CS, Crews BC, Kozak KR, Morrow JD, Marnett LJ. The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells. PNAS 2004 101 : 1840 5.
24. Wahn H, Wolf J, Kram F, Frantz S, Wagner JA. The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs. Am J Physiol Heart Circ Physiol 2005 289 : H2491 H2496.
25. Höcherl K, Dreher F, Kurtz A, Bucher M. Cyclooxygenase-2 inhibition attenuates lipopolysaccharide-induced cardiovascular failure. Hypertension 2002 40 : 947 53.